Hwai Wen Chang - Concepedia

Author

Hwai Wen Chang

Scripps Research Institute ORCID

Also Known As

H W Chang, Hwai Wen Chang

Publications

817

Citations

H-Index

Concepts

All Affiliations

Scripps Research Institute Torrey Pines Institute For Molecular Studies BioAtla (United States)

About

Hwai Wen Chang is an author at Scripps Research Institute specializing in cell signaling, signal transduction, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	87
2	Cell Biology	2	2	87
3	Natural Sciences	1	1	68
4	Cellular Physiology	1	1	68
5	Immunology	1	1	19

Hwai Wen Chang

Publications

803

Citations

H-Index

Page 1

	Year	Citations
Transformation of Chicken Cells by the Gene Encoding the Catalytic Subunit of PI 3-Kinase Hwai Wen Chang, Masahiro Aoki, David Fruman, Science	1997	415
α-Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats Tiebing Liang, John C. H. Spence, Lixiang Liu, Proceedings of the National Academy of Sciences	2003	126
The Catalytic Subunit of Phosphoinositide 3-Kinase: Requirements for Oncogenicity Masahiro Aoki, Christian Schetter, Martin Himly, Journal of Biological Chemistry	2000	87
Y box-binding protein 1 induces resistance to oncogenic transformation by the phosphatidylinositol 3-kinase pathway Andreas G. Bader, Katherine A. Felts, Ning Jiang, Proceedings of the National Academy of Sciences Phosphatidylinositol 3-Kinase PathwayMolecular RegulationMolecular BiologyOncogenic TransformationSaturation Density	2003	68
Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches Hwai Wen Chang, Gerhard Frey, Haizhen Liu, Proceedings of the National Academy of Sciences	2021	43
Oncogenic transformation induced by the Qin protein is correlated with transcriptional repression Jian Li, Holger Thurm, Hwai Wen Chang, Proceedings of the National Academy of Sciences	1997	35
A novel conditional active biologic anti-EpCAM x anti-CD3 bispecific antibody with synergistic tumor selectivity for cancer immunotherapy Gerhard Frey, Ana Paula G. Cugnetti, Haizhen Liu, mAbs ImmunologySynergistic Tumor SelectivityImmunotherapyCancer BiologyTumor Biology	2024	19
A random walk in oncogene space: the quest for targets. Peter K. Vogt, Masahiro Aoki, Ivan Bottoli, PubMed	1999	10

Page 1